The company aims to develop and maintain intellectual property in the field of stem cell research and regenerative therapy, which enable the restoration of damaged tissue in the human body, accelerate recovery, and improve long-term outcomes for patients. The company may acquire, encumber, dispose of, mediate, and manage real estate both domestically and abroad, establish branches both domestically and abroad, acquire stakes in domestic and foreign companies, found subsidiaries both domestically and abroad, and enter into any transactions and conclude any contracts that are suitable to promote the purpose of the company directly or indirectly.